Close the acquisition of OneOncology
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 20 Apr 2023
- Due
- 30 Sep 2023
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“The transaction is expected to close by the end of September 2023 and is subject to the satisfaction of customary closing conditions, including receipt of required regulatory approvals.”
What we found
Evidence strength A What the grades mean
Filings say Cencora invested $718.4 million for a 34.9% stake in the OneOncology joint venture in June 2023, before the September 2023 deadline.
-
A Cencora 10-K filed 2023-11-21
“net cash used in investing activities in the fiscal year ended September 30, 2023 included $1,406.5 million for the acquisition of PharmaLex and $718.4 million for our investment in OneOncology” ✓ confirmed on the page
-
A Cencora 10-K filed 2024-11-26
“In June 2023, we invested $718.4 million (representing a 34.9% interest) in a joint venture to acquire OneOncology, a network of leading oncology practices, with TPG” ✓ confirmed on the page
Market reaction: the shares moved +2.5% against the S&P 500 over the three sessions around the disclosure (20 Nov 2023 to 24 Nov 2023). What this measures
Checked 10 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Acquisition close
- Indicative materiality
- High rules
- Action
- Close
- Deliverable
- OneOncology acquisition
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: satisfaction of customary closing conditions; receipt of required regulatory approvals
- Depends on
- Regulatory, Counterparty
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Cencora? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2023-COR-005507 · Corrections policy